[Leu15]-Gastrin I (human)

[Leu15]-Gastrin I (human) is a synthetic peptide analogue of human gastrin, distinguished by the substitution of leucine at position 15. As a member of the gastrointestinal peptide hormone family, it plays a critical role in the regulation of gastric acid secretion and mucosal growth. The structural modification in this analogue allows researchers to investigate the functional implications of amino acid substitutions within the gastrin sequence, providing a valuable tool for dissecting peptide-receptor interactions, signaling pathways, and structure-activity relationships in gastrointestinal physiology and peptide pharmacology.

Receptor binding studies: The modified sequence of [Leu15]-Gastrin I enables detailed analysis of its affinity and selectivity for the cholecystokinin B (CCK-B) receptor. By comparing its binding characteristics to those of native gastrin peptides, researchers can delineate the contributions of specific residues to receptor recognition and activation. Such studies are essential for mapping receptor-ligand interfaces, elucidating the molecular determinants of peptide hormone activity, and supporting the rational design of receptor-specific ligands for biochemical and pharmacological research.

Peptide structure-activity relationship investigations: The substitution of leucine at the 15th position makes this peptide a strategic probe for exploring how sequence variations affect biological potency and specificity. Through in vitro assays and biophysical analyses, scientists can assess the impact of this modification on peptide stability, conformational dynamics, and downstream signaling efficacy. These insights are fundamental for understanding the principles governing peptide hormone function and for developing analogues with tailored properties for experimental applications.

Gastrointestinal signaling pathway elucidation: [Leu15]-Gastrin I serves as a functional tool for dissecting the intracellular signaling cascades triggered by gastrin receptor engagement. In cellular and tissue-based models, it can be used to stimulate or modulate pathways such as phospholipase C activation, calcium mobilization, and gene expression relevant to gastric mucosa physiology. This facilitates mechanistic studies of hormone-regulated cellular processes, supports the identification of downstream effectors, and aids in the development of pathway-specific modulators for research use.

Peptide synthesis and analytical method validation: Due to its defined sequence and well-characterized properties, [Leu15]-Gastrin I is frequently employed as a reference standard or model compound in peptide synthesis optimization and analytical method development. Its use in high-performance liquid chromatography (HPLC), mass spectrometry, and other analytical platforms enables laboratories to validate peptide purity, assess synthetic efficiency, and benchmark detection sensitivity, thereby enhancing the reliability of peptide production and quality control protocols.

Functional studies in tissue and organ models: The biological activity of this gastrin analogue makes it suitable for ex vivo and in vitro experiments involving gastric tissue preparations, organoids, and primary cell cultures. By applying [Leu15]-Gastrin I to these systems, researchers can monitor physiological responses such as acid secretion, cellular proliferation, and gene regulation. These functional assays contribute to a deeper understanding of peptide-mediated regulation in the gastrointestinal tract and provide a foundation for comparative studies with other hormone analogues.

1. The spatiotemporal control of signalling and trafficking of the GLP-1R

2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

3. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

4. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

5. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling